Adjuvant radiotherapy halved recurrence risk after complete resection of atypical meningioma
ROAM/EORTC-1308 improved 5-year disease-free survival from 64.3% to 79.9% after complete resection of WHO grade 2 meningioma.
ROAM/EORTC-1308 improved 5-year disease-free survival from 64.3% to 79.9% after complete resection of WHO grade 2 meningioma.
After surgery plus 66–70 Gy, only one of six patients recurred locally, while half developed distant metastases.
After propensity matching, overall survival was similar between surgery plus adjuvant RT and definitive RT, while disease-control differences remained non-significant.
Adjuvant radiotherapy did not improve recurrence-free or overall survival, but concurrent systemic therapy did not increase radiotherapy-related toxicity.
Adding vaginal cuff brachytherapy to whole pelvis radiation therapy was associated with improved overall survival in stage II endometrioid endometrial cancer.